Advanced Practice Nurse Specializing in Emergency Care and Post-emergency Consultation: Feasibility Study (CPU - IPA)

February 9, 2026 updated by: Centre Hospitalier Régional Metz-Thionville

Advanced Practice Nurse Specializing in Emergency and Post-emergency Care: Towards Improved Unscheduled Care?

Emergency departments are facing increasing overload, exacerbated by difficulties in accessing primary care. This saturation impacts the fluidity of care pathways and the quality of care.

A major challenge is the high rate of short-term repeat visits, which increases the workload. These early returns may be due to an unexpected change in the patient's condition, but also to the difficulty of obtaining a quick appointment with a general practitioner, due to a shortage of practitioners or a lack of available slots within a few days.

Study Overview

Status

Completed

Conditions

Detailed Description

In this context, the implementation of a Post-Emergency Consultation by an Advanced Practice Nurse could be a solution to improve patient follow-up and limit these avoidable return visits.

Main objective: Identify the profiles of patients who return for a second consultation within 15 days of their first visit to the emergency department.

Secondary objectives:

  • Describe the characteristics of these patients (age, gender, medical history, pathologies, reasons for the initial consultation, reasons for the repeat consultation).
  • Analyze medical records to assess whether a post-emergency consultation by an APN could have prevented this repeat consultation.

Study Type

Observational

Enrollment (Actual)

328

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Metz, France, 57085
        • CHR Metz-Thionville

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients who visited the emergency department and were seen again within 15 days.

Description

Inclusion Criteria:

  • Patients who visited the emergency department at 15-day intervals during the study period

Exclusion Criteria:

  • Patients hospitalized at the time of the first consultation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage patients who return for a second consultation
Time Frame: 15 days
Percentage of patients who return for a second consultation within 15 days of their first visit to the emergency department and prifile of patients
15 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre Hospitalier Régional Metz-Thionville

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2025

Primary Completion (Actual)

June 30, 2025

Study Completion (Actual)

June 30, 2025

Study Registration Dates

First Submitted

January 27, 2026

First Submitted That Met QC Criteria

February 9, 2026

First Posted (Actual)

February 12, 2026

Study Record Updates

Last Update Posted (Actual)

February 12, 2026

Last Update Submitted That Met QC Criteria

February 9, 2026

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2025-05-Obs-CHRMT

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthcare Access

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe